IL1RL2 and generalized pustular psoriasis: With the success of anti-IL-36 receptor monoclonal antibody treatment in generalized pustular psoriasis (19), the potential role of IL-36 in the pathogenesis of chronic plaque-type psoriasis has also been reported (19, 20).